Document is current
Any future updates will be listed below
-
Authors
Hocking, Lynne J. http://orcid.org/0000-0002-2414-2826
Andrews, Claire
Armstrong, Christine
Ansari, Morad http://orcid.org/0000-0002-8905-5379
Baty, David
Berg, Jonathan
Bradley, Therese
Clark, Caroline
Diamond, Austin http://orcid.org/0000-0002-9615-229X
Doherty, Jill
Lampe, Anne
McGowan, Ruth
Moore, David J.
O’Sullivan, Dawn
Purvis, Andrew
Santoyo-Lopez, Javier http://orcid.org/0000-0003-1988-5059
Westwood, Paul
Abbott, Michael
Williams, Nicola
,
Aitman, Timothy J.
Biankin, Andrew V.
Cooke, Susanna L.
Humphrey, Wendy Inglis
Martin, Sancha
Meynert, Alison
Murphy, Fiona
Nourse, Craig
Semple, Colin A.
Williams, Nicola
Dean, John
Foley, Patricia
Robertson, Lisa
Ross, Alison
Williamson, Karen
Berg, Jonathan
Goudie, David
McWilliam, Catherine
Fitzpatrick, David
Fletcher, Elaine
Jackson, Andrew
Lam, Wayne
Porteous, Mary
Barr, Kate
Bradshaw, Nicola
Davidson, Rosemarie
Gardiner, Carol
Gorrie, Jennifer
Hague, Rosie
Hamilton, Mark
Joss, Shelagh
Kinning, Esther
Longman, Cheryl
Martin, Neil
McGowan, Ruth
Paterson, Jenny
Pilz, Daniela
Snadden, Lesley
Tobias, Edward
Wedderburn, Sarah
Whiteford, Margo
Aitman, Timothy J. http://orcid.org/0000-0002-7875-4502
Miedzybrodzka, Zosia http://orcid.org/0000-0003-2890-8136
-
Funding
Funding for this research was provided by:
Chief Scientist Office (SGP/1 and HIPS/19/17, HIPS-19-17, SGP/1)
RCUK | Medical Research Council (MC/PC/15080, MC/PC/15080)
DH | NIHR | Service Delivery and Organisation Programme
Wellcome Trust
Cancer Research UK
- License Information
-
More Information
Article History
Received: 17 August 2022
Revised: 14 October 2022
Accepted: 25 October 2022
First Online: 6 December 2022
Competing interests
: TJA is co-founder and Director of the company BioCaptiva, has received conference attendance expenses from Illumina and is a signatory to an early access agreement for Illumina technology. All other authors declare no competing interests.
: This research study was approved by North of Scotland Research Ethics Committee (16/NS/0137) and Scotland A Research Ethics Committee (17/SS/0113); the Public Benefit and Privacy Panel (1516-0377); and NHS Scotland health board Research and Development departments. Informed consent was obtained from all individuals who took part in the SGP Study, as per REC approvals. All data were de-identified prior to analysis.
